Cannara Biotech (LOVE) Price & Analysis

Compare

33 Followers

LOVE Stock Chart & Stats

Day’s Range― - ―

52-Week RangeC$0.57 - C$1.99

Previous CloseN/A

Volume7.64K

Average Volume (3M)146.00K

Market Cap

C$176.47M

Enterprise ValueC$149.75M

Total Cash (Recent Filing)C$5.06M

Total Debt (Recent Filing)C$48.86M

Price to Earnings (P/E)11.3

Beta-0.01

Next Earnings

Dec 02, 2025

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)0.04

Shares Outstanding91,433,136

10 Day Avg. Volume151,002

30 Day Avg. Volume146,000

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)0.00

Price to Sales (P/S)0.00

P/FCF Ratio0.00

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price Target

C$2.00

Price Target Upside6.24% Upside

Rating ConsensusModerate Buy

Number of Analyst Covering1

Cannara Biotech News

Cannara Biotech reports Q3 EPS C$0.05 vs. C$0.02 last year

Reports Q3 revenue C$27.3M vs. C$19.5M last year. “Fiscal Q3 2025 represents another record-breaking quarter for Cannara, producing...

11d ago

Cannara Biotech secures five listings in Quebec’s vape cartridge category

Cannara Biotech (LOVFF) announced the preliminary acceptance by the Societe Quebecoise du Cannabis of five vape cartridge products...

15d ago

Cannara Biotech Reports Record Q3 2025 Earnings

Cannara Biotech, Inc. ( ($LOVFF) ) has released its Q3 earnings. Here is a breakdown of the information...

11d ago

Cannara Biotech Achieves Record Revenue and Profitability in Q3 2025

Cannara Biotech ( ($TSE:LOVE) ) has issued an announcement. Cannara Biotech reported its highest revenue and profitability since...

11d ago

Cannara Biotech Expands into Québec’s Vape Market with New Product Launch

An update from Cannara Biotech ( ($TSE:LOVE) ) is now available. Cannara Biotech has secured preliminary acceptance from...

15d ago

Cannara Biotech to Release Q3 2025 Financial Results

Cannara Biotech ( ($TSE:LOVE) ) has provided an update. Cannara Biotech Inc. announced it will release its fiscal...

18d ago

Cannara Biotech to Host Investor Webcast on Business Operations

Cannara Biotech ( ($TSE:LOVE) ) has provided an announcement. Cannara Biotech announced that it will host an investor...

2M ago

Cannara Biotech Wins Awards and Reduces Debt Costs

The latest update is out from Cannara Biotech ( ($TSE:LOVE) ). Cannara Biotech Inc. announced its Tribal brand...

2M ago

Cannara reduces cost of debt with lower interest rate, partial debenture payment

The Company announced it has made a $1M repayment against the outstanding convertible debenture originally issued on June...

2M ago

Cannara Biotech Shines in Latest Earnings Call

Cannara Biotech, Inc. (($TSE:LOVE)) has held its Q2 earnings call. Read on for the main highlights of the...

3M ago

Cannara Biotech Reports Record Q2 2025 Earnings

Cannara Biotech, Inc. ( ($LOVFF) ) has released its Q2 earnings. Here is a breakdown of the information...

3M ago

Cannara Biotech Achieves Record Q2 2025 Results Amid National Expansion

Cannara Biotech ( ($TSE:LOVE) ) just unveiled an announcement. Cannara Biotech reported record financial results for Q2 2025,...

3M ago

Cannara Biotech reports Q2 EPS C$0.04 vs. (C$0.04) last year

Reports Q2 net revenue C$26.6M vs. C$19.7M last year.”Q2 2025 marks another record quarter for Cannara, driven by...

3M ago

Cannara Biotech to Release Q2 2025 Financial Results

An announcement from Cannara Biotech ( ($TSE:LOVE) ) is now available. Cannara Biotech Inc. announced it will release...

4M ago

LOVE FAQ

What was Cannara Biotech, Inc.’s price range in the past 12 months?

Cannara Biotech, Inc. lowest stock price was C$0.57 and its highest was C$1.99 in the past 12 months.

What is Cannara Biotech, Inc.’s market cap?

Cannara Biotech, Inc.’s market cap is C$176.47M.

When is Cannara Biotech, Inc.’s upcoming earnings report date?

Cannara Biotech, Inc.’s upcoming earnings report date is Dec 02, 2025 which is in 116 days.

How were Cannara Biotech, Inc.’s earnings last quarter?

Cannara Biotech, Inc. released its earnings results on Jul 28, 2025. The company reported C$0.04 earnings per share for the quarter, beating the consensus estimate of N/A by C$0.04.

Is Cannara Biotech, Inc. overvalued?

According to Wall Street analysts Cannara Biotech, Inc.’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does Cannara Biotech, Inc. pay dividends?

Cannara Biotech, Inc. does not currently pay dividends.

What is Cannara Biotech, Inc.’s EPS estimate?

Cannara Biotech, Inc.’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Cannara Biotech, Inc. have?

Cannara Biotech, Inc. has 91,433,136 shares outstanding.

What happened to Cannara Biotech, Inc.’s price movement after its last earnings report?

Cannara Biotech, Inc. reported an EPS of C$0.04 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 0.562%.

Which hedge fund is a major shareholder of Cannara Biotech, Inc.?

Currently, no hedge funds are holding shares in TSE:LOVE

Company Description

Cannara Biotech, Inc.

Cannara Biotech (LOVE) is a Canadian company operating in the cannabis sector. It is focused on the cultivation and sale of premium cannabis products. The company leverages its state-of-the-art production facilities in Quebec to produce high-quality cannabis for both the medical and recreational markets. Its core products include dried cannabis flower, pre-rolls, and other derivative products.

Cannara Biotech (LOVE) Earnings & Revenues

Historic Earnings Reports

LOVE Earnings Call

Q3 2025

0:00 / 0:00

Earnings Call Sentiment|Positive

Cannara Biotech demonstrated strong financial performance and market share growth, primarily driven by innovative product launches and operational efficiencies. However, they faced challenges in maintaining market share in certain provinces and managing cash flow. Overall, the positive achievements significantly outweigh the challenges.View all TSE:LOVE earnings summaries

LOVE Stock 12 Month Forecast

Average Price Target

C$2.00

▲(6.24% Upside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"2":"C$2","-1":"-C$1","-0.25":"-C$0.25","0.5":"C$0.5","1.25":"C$1.25"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":1.997338721,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">C$2.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":1.997338721,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">C$2.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":1.997338721,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">C$2.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[-1,-0.25,0.5,1.25,2],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Nov<br/>2024","6":"Jan<br/>2025","9":"Apr<br/>2025","12":"Jul<br/>2025","25":"Jul<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1.41,1.4551799016153846,1.5003598032307692,1.5455397048461537,1.5907196064615383,1.635899508076923,1.6810794096923076,1.7262593113076923,1.771439212923077,1.8166191145384616,1.8617990161538462,1.9069789177692307,1.9521588193846153,{"y":1.997338721,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1.41,1.4551799016153846,1.5003598032307692,1.5455397048461537,1.5907196064615383,1.635899508076923,1.6810794096923076,1.7262593113076923,1.771439212923077,1.8166191145384616,1.8617990161538462,1.9069789177692307,1.9521588193846153,{"y":1.997338721,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1.41,1.4551799016153846,1.5003598032307692,1.5455397048461537,1.5907196064615383,1.635899508076923,1.6810794096923076,1.7262593113076923,1.771439212923077,1.8166191145384616,1.8617990161538462,1.9069789177692307,1.9521588193846153,{"y":1.997338721,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":0.62,"date":1722470400000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":0.68,"date":1725148800000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":0.61,"date":1727740800000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":0.7,"date":1730419200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":0.83,"date":1733011200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":0.74,"date":1735689600000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":0.74,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.09,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.38,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.31,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.44,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.22,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.41,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >